Jan-04 revised [News] Free Access to Papers Related to the Novel Coronavirus (COVID-19) (Important)
In order to support the research on the Novel Coronavirus (COVID-19), some publishers have set up special sites and sent related information, and published related papers for free, so we will introduce them.
In order to support the research on the Novel Coronavirus (COVID-19), some publishers have set up special sites and sent related information, and published related papers for free, so we will introduce them.
● Free Access to information of COVID-19 |
|||
Publishers | contents | notes | |
AAP News | COVID -19 AAP (American Academy of Pediatrics) News Summary | - | |
ACP(American College of Physicians) | COVID -19 : Information for Internists | - | |
AIP Publishing | Free access to the company's COVID-19 literature | - | |
American Chemical Society | Free access to the company's COVID -19 literature | - | |
American Psychological Association | Free access to the company's COVID -19 literature | - | |
American Society for Microbiology | COVID -19 Information Summary Site | - | |
Annals of Internal Medicine | Free access to the COVID -19 literature | - | |
ASCO | Resources to support clinicians, the cancer care delivery team, and patients with cancer | - | |
BioOne | Free access to the company's "Coronavirus" and "Pandemic" literature | - | |
BMJ Publishing Group | Free access to the company's COVID -19 literature | - | |
Cambridge University Press | Free access to the company's COVID -19 literature | - | |
Cell Press | Free access to the company's COVID -19 literature | - | |
Dynamed | Open the COVID -19 Related Resources Page | - | |
EBSCO | Open the COVID -19 Related Resources Page | - | |
EBSCO | Open the COVID -19 Information Portal | - | |
Elsevier | Free publication of documents on COVID -19 from the company and other companies | - | |
JAMA | Free access to the company's COVID -19 literature | - | |
JoVE | Free Experiment Videos on COVID -19 | - | |
Japan Medical Abstracts Society(ICHUSHI) | COVID -19 Information Summary Site | ||
JSTOR | Free access to the company's COVID -19 literature | - | |
Karger | Free access to the company's COVID -19 literature | - | |
Lifescience Pub | Free access to information on COVID -19 and related pages on pneumonia and respiratory infections |
in Japanese |
|
LitCovid(NCBI) | Information hub curated from the latest scientific literature on COVID -19 | - | |
MaryAnnLiebert | Free access to the company's COVID -19 literature | - | |
McGraw-Hill Education | Free access to the company's COVID -19 literature | - | |
Microbiology Society | Free access to the company's COVID -19 literature | - | |
NIH | COVID -19 Information Summary Site | - | |
Ovid | Portal page with expert search, widgets, and links to resources and tools like GIDEON (Global Infectious Diseases and Epidemiology Network) for the latest information on New Coronavirus. | - | |
Oxford University Press | Free access to the company's COVID -19 literature | - | |
PNAS | Free access to the company's COVID -19 literature | - | |
ProQuest | Coronavirus Research Database | - | |
PubMed(URL for NU) | Example search expression (Please copy and paste it in the search window) 2019-nCoV OR 2019nCoV OR COVID-19 OR SARS-CoV-2 OR ((wuhan AND coronavirus) AND 2019/12[PDAT]:2030[PDAT]) |
- | |
Royal Society | Free access to the company's COVID -19 literature | - | |
Royal Society of Chemistry | Free access to the company's COVID -19 literature | - | |
RSNA(Radiological Society of North America | Free access to the company's COVID -19 literature | - | |
Sage Publishing | Free access to the company's COVID -19 literature | - | |
SIAM (Society for Industrial and Applied Mathematics) | Free access to the company's COVID -19 literature | - | |
Springer Nature | Free access to the company's COVID -19 literature | - | |
Taylor & Francis | Free access to the company's COVID -19 literature | - | |
Thieme | Free access to the company's COVID -19 literature | - | |
Wiley | Free access to the company's COVID -19 literature | - | |
Wolters Kluwer | Free access to the latest information and resources on COVID-19. | - |
Document Actions
Document Actions